ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2816

Pilot Phase Outcomes From The ACR/Carra Inter-Institutional Mentoring Program In Pediatric Rheumatology

Peter A. Nigrovic1,2, Eyal Muscal3, Lakshmi N. Moorthy4, Sampath Prahalad5, Marisa S. Klein-Gitelman6, Meredith P. Riebschleger7, B. Anne Eberhard8 and Rayfel Schneider9, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 3TCH Pediatric Rheum Center, Baylor College of Medicine, Houston, TX, 4Pediatric Rheumatology, Robert Wood Johnson Medical School-Rutgers University, New Brunswick, NJ, 5Pediatrics, Emory Children's Center, Atlanta, GA, 6Division of Rheumatology, Children's Memorial Hospital, Chicago, IL, 7Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, 8Cohen Children's Hospital Medical Center, New Hyde Park, NY, 9Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati, OH, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Career, Education, educational innovation and evaluation, medical

  • Tweet
  • Email
  • Print
Session Information

Title: Medical Education

Session Type: Abstract Submissions (ACR)

Background/Purpose: In pediatric rheumatology, the small size of many academic programs translates into limited mentoring options for early career physicians. To address this “mentorship gap,” the American College of Rheumatology (ACR) and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) joined together to develop AMIGO, the ACR/CARRA Mentoring Interest Group, that now enrolls more than 80 pediatric rheumatology fellows and junior faculty in the US and Canada. We report program evaluation data from the AMIGO pilot project, launched in November 2011 with 20 mentor-mentee dyads.

Methods:  Mentees and mentors participating in the AMIGO pilot phase were surveyed via online questionnaire 17 months after initial match to determine dynamics of contact and perceived benefit in domains relevant to professional success and work-life balance.

Results:  Of 20 initial matches, 19 were still functioning while one had dissolved due to departure of the mentee from North America. Ninety-five percent of the participants reported at least two substantial interactions. Total mentoring time was estimated at under 60 minutes by approximately half of respondents, though 20% reported more than 3 hours of interaction. Thirty-one percent of participants rated the quality of the match as good and 51% as excellent (defined as ‘excellent overlap of mentee needs and mentor experience’).  All mentees considered the mentoring helpful in providing career guidance, with substantial benefit also in scholarship, and job satisfaction. Benefits reported by mentors included improvement of their mentoring skills and development of their academic portfolios. Both mentees and mentors reported improved connectedness to the wider pediatric rheumatology community. All participants favored continuation of the program (Table 1).

Table 1. Pilot survey data at 17 months after initiation of a mentoring program

 

Mentees  (n, %)

Mentors (n, %)

Overall (n, %)

Responses (%)

18/19 (95)

19/19 (100)

37/38 (97)

Benefit to mentee

 

 

 

Career path/job search

18 (100)

13 (68)

31 (84)

Research/scholarship

12 (67)

10 (53)

22 (59)

Job satisfaction

13 (72)

12/17 (71)

25/35 (71)

Work-life balance

8 (44)

12/18 (67)

20/36 (56)

Benefit to mentors

 

 

 

Mentoring skills

NA

12/18 (67)

NA

Professional portfolio

NA

8/17 (47)

NA

Enhanced connection to community

14/17 (82)

14 (75)

28/36 (78)

Should AMIGO be continued?

18 (100)

19 (100)

37 (100)

Conclusion: The success of the pilot AMIGO program indicates that a North American inter-institutional mentoring program in pediatric rheumatology is feasible.  Participants identified benefits to both mentees and mentors in multiple domains, most prominently in career guidance, a core goal of the program.  Although longer-term evaluation of the full AMIGO program is needed, the success of the pilot program suggests that AMIGO could serve as a model for mentoring more broadly within the ACR and potentially in other medical subspecialties.


Disclosure:

P. A. Nigrovic,

Baxter Healthcare,

2,

Novartis Pharmaceutical Corporation,

5;

E. Muscal,
None;

L. N. Moorthy,
None;

S. Prahalad,
None;

M. S. Klein-Gitelman,
None;

M. P. Riebschleger,
None;

B. A. Eberhard,
None;

R. Schneider,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pilot-phase-outcomes-from-the-acrcarra-inter-institutional-mentoring-program-in-pediatric-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology